Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Roberto Ovilla"'
Autor:
Andrés Gómez-De León, Roberta Demichelis-Gómez, Alfredo Pinedo-Rodríguez, Daniel Enriquez-Vera, Juan Antonio Flores-Jiménez, Adrián Alejandro Ceballos-López, Margarita Rodríguez-Mejorada, Miguel Angel Herrera Riojas, Roberto Ovilla-Martínez, Pamela Báez-Islas, Xóchitl Cota-Rangel, Yvette Neme-Yunes, Sergio Inclán-Alarcón, Nelson J. López-Flores, Perla R. Colunga-Pedraza, Anna C. Rodríguez-Zúñiga, David Gómez-Almaguer
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 249-257 (2022)
Objectives: Venetoclax combinations are a new standard for patients with acute myeloid leukemia (AML). We aimed to evaluate the safety and efficacy of these combinations in a period of accelerated approval in Latin-America. Methods: This observationa
Externí odkaz:
https://doaj.org/article/432b0ee68d524155a471093605e2ce2c
Autor:
Miguel Pavlovsky, Daniel Cubero, Gladys Patricia Agreda-Vásquez, Alicia Enrico, Maria J. Mela-Osorio, Jorge Armenta San Sebastián, Laura Fogliatto, Roberto Ovilla, Oscar Avendano, Gerardo Machnicki, Paula Barreyro, Damila Trufelli, Pamella Villanova
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEReal-world evidence on non-Hodgkin lymphoma (NHL) management in Latin America is currently lacking. The objective of this study was to describe treatment characteristics and outcomes of NHL in Latin America.METHODSA total of 2,967 patients wit
Externí odkaz:
https://doaj.org/article/5d86b96d9bdb43e3a68482e339379925
Autor:
Katja Weisel, Andrew Spencer, Suzanne Lentzsch, Hervé Avet-Loiseau, Tomer M. Mark, Ivan Spicka, Tamas Masszi, Birgitta Lauri, Mark-David Levin, Alberto Bosi, Vania Hungria, Michele Cavo, Je-Jung Lee, Ajay Nooka, Hang Quach, Markus Munder, Cindy Lee, Wolney Barreto, Paolo Corradini, Chang-Ki Min, Asher A. Chanan-Khan, Noemi Horvath, Marcelo Capra, Meral Beksac, Roberto Ovilla, Jae-Cheol Jo, Ho-Jin Shin, Pieter Sonneveld, Tineke Casneuf, Nikki DeAngelis, Himal Amin, Jon Ukropec, Rachel Kobos, Maria-Victoria Mateos
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Background Multiple myeloma (MM) patients with high cytogenetic risk have poor outcomes. In CASTOR, daratumumab plus bortezomib/dexamethasone (D-Vd) prolonged progression-free survival (PFS) versus bortezomib/dexamethasone (Vd) alone and exh
Externí odkaz:
https://doaj.org/article/f4bcd4b8584c4c2d8d002b323f628268
Autor:
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, Lina M. Abenoza, Gladys P. Agreda, Jorge Armenta, Celso Arrais, Oscar Avendaño Flores, Fernando Barroso, Ana L. Basquiera, Carmen Cao, Maria S. Cugliari, Alicia Enrico, Laura M. Foggliatto, Kenny M. Galvez, David Gomez, Alvaro Gomez, Daniel de Iracema, Danielle Farias, Lineth Lopez, William Armando Mantilla, Deborah Martínez, Maria Jose Mela, Carlos E. Miguel, Roberto Ovilla, Luis Palmer, Carolina Pavlovsky, Christian Ramos, Guillermina Remaggi, Rodrigo Santucci, Sergio Schusterschitz, Claudia Lucia Sossa, Elena Tuna-Aguilar, Jorge Vela, Telma Santos, Odin de la Mora, Gerardo Machnicki, Mariana Fernandez, Paula Barreyro
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-19 (2019)
PURPOSE: Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describ
Externí odkaz:
https://doaj.org/article/e1cf84fea5fb415293927848125b0db5
Autor:
Roberto Ovilla-Martínez, Pamela E. Báez-Islas, Xóchitl Cota-Rangel, Antonio de la Peña-Celaya
Publikováno v:
Gaceta Médica de México, Vol 157, Iss 93 (2021)
Externí odkaz:
https://doaj.org/article/55ab613248294e4885f13fd7af5ae291
Autor:
Andrew Spencer, Suzanne Lentzsch, Katja Weisel, Hervé Avet-Loiseau, Tomer M. Mark, Ivan Spicka, Tamas Masszi, Birgitta Lauri, Mark-David Levin, Alberto Bosi, Vania Hungria, Michele Cavo, Je-Jung Lee, Ajay K. Nooka, Hang Quach, Cindy Lee, Wolney Barreto, Paolo Corradini, Chang-Ki Min, Emma C. Scott, Asher A. Chanan-Khan, Noemi Horvath, Marcelo Capra, Meral Beksac, Roberto Ovilla, Jae-Cheol Jo, Ho-Jin Shin, Pieter Sonneveld, David Soong, Tineke Casneuf, Christopher Chiu, Himal Amin, Ming Qi, Piruntha Thiyagarajah, A. Kate Sasser, Jordan M. Schecter, Maria-Victoria Mateos
Publikováno v:
Haematologica, Vol 103, Iss 12 (2018)
Daratumumab, a CD38 human monoclonal antibody, demonstrated significant clinical activity in combination with bortezomib and dexamethasone versus bortezomib and dexamethasone alone in the primary analysis of CASTOR, a phase 3 study in relapsed and/or
Externí odkaz:
https://doaj.org/article/a34eb4051074415eaed565a3bdec8188
Autor:
Roberto Ovilla-Martínez, Pamela E. Báez-Islas, Xóchitl Cota-Rangel, Antonio de la Peña-Celaya
Publikováno v:
Gaceta Médica de México. 157
Autor:
Roberto Ovilla-Martinez, Xochitl Cota-Rangel, Jose De La Peña-Celaya, Mariana Alejandra Alvarado-Zepeda, Alejandro Jiménez Sastré, Humberto Azuara Forcelledo, Bernardino Ordoñez Rodriguez, Juan Pulido Broca, Aaron Molina Jaimes, Alejandro Muñiz-Carvajal, Maria Magdalena Bahena García, Eduardo Cervera Ceballos, Nidia Paulina Zapata Canto, Jorge Oscar García Mendez, Omar Noel García Jímenez, Jesus Alberto Salas Heredia, Javier Solis Soto, Ruben Alberto Villalobos Mendez, Gregorio Ignacio Ibarra, Cindy Ledesma de la Cruz, Nora Araujo Martinez, Jessi Juárez Lara, Cecilio Omar Ceballos Zuñiga, Felipe Vicente Villaseñor Pérez, Jose Carlos Herrera Garcia, Patricia Nuche Salazar, Alfredo Dominguez Paregrina, Bertha Arizpe Bravo, Gabriela Enciso Figueroa, Teresita Trujillo, Adriana Miguel Álvarez, Diego de Jesús García Gallegos, Alejandro Ortiz Arroyo, Claudia Ivette Solorzano Soto, Hiram Javier Jaramillo Ramírez, Ibis De la Cruz Hernández, Sergio De Gante Martínez, Guadalupe Esmeralda Montesinos Gómez, Silvia Martínez Velasco, Roberto García Graullera, Miguel Angel Vázquez López, Victor Itaí Urbalejo Ceniceros, Yolanda Lugo García, Ana Itamar González Ávila, Jorge Duque Rodriguez, Rodolfo Ruiz Luján, Violeta I. Rodríguez Rivera, Lucio Soberanes Ramírez, Pamela Elena Baez-Islas
Publikováno v:
The Journal of Infection in Developing Countries. 16:63-72
Introduction: Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) infection is characterised by a viral phase and a severe pro-inflammatory phase. The inhibition of the JAK/STAT pathway limits the pro-inflammatory state in moderate to
Autor:
Xóchitl Cota-Rangel, Pamela Elena Báez-Islas, José Antonio de la Peña-Celaya, Roberto Ovilla-Martínez
Publikováno v:
Latin american journal of clinical sciences and medical technology. 2:83-86
Background. Due to a high rate of contagion, COVID-19 has become a pandemic with an increasing rate of hospitalization and mortality. The main complication is the hyperimmune response caused by the pro-inflammatory cytokines like IL-1, IL-6, IFN-g, a
Autor:
Telma Santos, Fernando Barroso, Luis Palmer, Carmen Cao, Maria Silvana Cugliari, Alicia Enrico, David M. Gómez, Gerardo Machnicki, Carlos E. Miguel, Maria Jose Mela, Mariana Fernandez, Oscar Avendaño Flores, Odin de la Mora, Jorge Armenta, Danielle Leão Cordeiro de Farias, Daniel de Iracema, Celso Arrais, Vania Hungria, Sergio Schusterschitz, Kenny Galvez, Christian Ramos, Laura M. Foggliatto, Gladys Agreda, Lineth Lopez, Jorge Vela, William Mantilla, Rodrigo Santucci, Elena J Tuna-Aguilar, Carolina Pavlovsky, Miguel A. Pavlovsky, Carlos S. Chiattone, Alvaro Gomez, Roberto Ovilla, Claudia Sossa, Deborah Martínez, Lina M. Abenoza, Ana Lisa Basquiera, Paula Barreyro, Guillermina Remaggi
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-19 (2019)
Journal of Global Oncology
Journal of Global Oncology
PURPOSE Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describe